Global Patient In-vivo Dosimetry (IVD) System Market Research Report 2021

1 Patient In-vivo Dosimetry (IVD) System Market Overview

• 1.1 Product Overview and Scope of Patient In-vivo Dosimetry (IVD) System
• 1.2 Patient In-vivo Dosimetry (IVD) System Segment by Type
  • 1.2.1 Global Patient In-vivo Dosimetry (IVD) System Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 Portable
  • 1.2.3 Fixed
• 1.3 Patient In-vivo Dosimetry (IVD) System Segment by Application
  • 1.3.1 Global Patient In-vivo Dosimetry (IVD) System Sales Comparison by Application: (2021-2027)
  • 1.3.2 Medical
  • 1.3.3 Scientific Research
  • 1.3.4 Others
• 1.4 Global Patient In-vivo Dosimetry (IVD) System Market Size Estimates and Forecasts
  • 1.4.1 Global Patient In-vivo Dosimetry (IVD) System Revenue 2016-2027
  • 1.4.2 Global Patient In-vivo Dosimetry (IVD) System Sales 2016-2027
  • 1.4.3 Patient In-vivo Dosimetry (IVD) System Market Size by Region: 2016 Versus 2021 Versus 2027

2 Patient In-vivo Dosimetry (IVD) System Market Competition by Manufacturers

• 2.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Patient In-vivo Dosimetry (IVD) System Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Patient In-vivo Dosimetry (IVD) System Manufacturing Sites, Area Served, Product Type
• 2.5 Patient In-vivo Dosimetry (IVD) System Market Competitive Situation and Trends
  • 2.5.1 Patient In-vivo Dosimetry (IVD) System Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Patient In-vivo Dosimetry (IVD) System Players Market Share by Revenue
  • 2.5.3 Global Patient In-vivo Dosimetry (IVD) System Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario by Region

• 3.1 Global Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Patient In-vivo Dosimetry (IVD) System Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
  • 3.3.1 North America Patient In-vivo Dosimetry (IVD) System Sales by Country
  • 3.3.2 North America Patient In-vivo Dosimetry (IVD) System Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
  • 3.4.1 Europe Patient In-vivo Dosimetry (IVD) System Sales by Country
  • 3.4.2 Europe Patient In-vivo Dosimetry (IVD) System Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Patient In-vivo Dosimetry (IVD) System Sales by Region
  • 3.5.2 Asia Pacific Patient In-vivo Dosimetry (IVD) System Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 China Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
  • 3.6.1 Latin America Patient In-vivo Dosimetry (IVD) System Sales by Country
  • 3.6.2 Latin America Patient In-vivo Dosimetry (IVD) System Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
• 3.7 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Sales by Country
  • 3.7.2 Middle East and Africa Patient In-vivo Dosimetry (IVD) System Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Patient In-vivo Dosimetry (IVD) System Historic Market Analysis by Type

• 4.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Type (2016-2021)
• 4.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Type (2016-2021)
• 4.3 Global Patient In-vivo Dosimetry (IVD) System Price by Type (2016-2021)

5 Global Patient In-vivo Dosimetry (IVD) System Historic Market Analysis by Application

• 5.1 Global Patient In-vivo Dosimetry (IVD) System Sales Market Share by Application (2016-2021)
• 5.2 Global Patient In-vivo Dosimetry (IVD) System Revenue Market Share by Application (2016-2021)
• 5.3 Global Patient In-vivo Dosimetry (IVD) System Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Landauer
  • 6.1.1 Landauer Corporation Information
  • 6.1.2 Landauer Description and Business Overview
  • 6.1.3 Landauer Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Landauer Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.1.5 Landauer Recent Developments/Updates
• 6.2 Chiyoda Technol Corporation
  • 6.2.1 Chiyoda Technol Corporation Corporation Information
  • 6.2.2 Chiyoda Technol Corporation Description and Business Overview
  • 6.2.3 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Chiyoda Technol Corporation Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.2.5 Chiyoda Technol Corporation Recent Developments/Updates
• 6.3 Mirion Technologies
  • 6.3.1 Mirion Technologies Corporation Information
  • 6.3.2 Mirion Technologies Description and Business Overview
  • 6.3.3 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 Mirion Technologies Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.3.5 Mirion Technologies Recent Developments/Updates
• 6.4 Thermo Fisher Scientific
  • 6.4.1 Thermo Fisher Scientific Corporation Information
  • 6.4.2 Thermo Fisher Scientific Description and Business Overview
  • 6.4.3 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Thermo Fisher Scientific Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.4.5 Thermo Fisher Scientific Recent Developments/Updates
• 6.5 Fuji Electric
  • 6.5.1 Fuji Electric Corporation Information
  • 6.5.2 Fuji Electric Description and Business Overview
  • 6.5.3 Fuji Electric Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Fuji Electric Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.5.5 Fuji Electric Recent Developments/Updates
• 6.6 Hitachi Aloka
  • 6.6.1 Hitachi Aloka Corporation Information
  • 6.6.2 Hitachi Aloka Description and Business Overview
  • 6.6.3 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 Hitachi Aloka Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.6.5 Hitachi Aloka Recent Developments/Updates
• 6.7 Bertin Instruments
  • 6.6.1 Bertin Instruments Corporation Information
  • 6.6.2 Bertin Instruments Description and Business Overview
  • 6.6.3 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Bertin Instruments Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.7.5 Bertin Instruments Recent Developments/Updates
• 6.8 Tracerco
  • 6.8.1 Tracerco Corporation Information
  • 6.8.2 Tracerco Description and Business Overview
  • 6.8.3 Tracerco Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 Tracerco Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.8.5 Tracerco Recent Developments/Updates
• 6.9 ATOMTEX
  • 6.9.1 ATOMTEX Corporation Information
  • 6.9.2 ATOMTEX Description and Business Overview
  • 6.9.3 ATOMTEX Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 ATOMTEX Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.9.5 ATOMTEX Recent Developments/Updates
• 6.10 Panasonic
  • 6.10.1 Panasonic Corporation Information
  • 6.10.2 Panasonic Description and Business Overview
  • 6.10.3 Panasonic Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Panasonic Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.10.5 Panasonic Recent Developments/Updates
• 6.11 Polimaster
  • 6.11.1 Polimaster Corporation Information
  • 6.11.2 Polimaster Patient In-vivo Dosimetry (IVD) System Description and Business Overview
  • 6.11.3 Polimaster Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Polimaster Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.11.5 Polimaster Recent Developments/Updates
• 6.12 Renri
  • 6.12.1 Renri Corporation Information
  • 6.12.2 Renri Patient In-vivo Dosimetry (IVD) System Description and Business Overview
  • 6.12.3 Renri Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Renri Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.12.5 Renri Recent Developments/Updates
• 6.13 RadPro International GmbH
  • 6.13.1 RadPro International GmbH Corporation Information
  • 6.13.2 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Description and Business Overview
  • 6.13.3 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 RadPro International GmbH Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.13.5 RadPro International GmbH Recent Developments/Updates
• 6.14 Ludlum Measurements
  • 6.14.1 Ludlum Measurements Corporation Information
  • 6.14.2 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Description and Business Overview
  • 6.14.3 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Ludlum Measurements Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.14.5 Ludlum Measurements Recent Developments/Updates
• 6.15 XZ LAB
  • 6.15.1 XZ LAB Corporation Information
  • 6.15.2 XZ LAB Patient In-vivo Dosimetry (IVD) System Description and Business Overview
  • 6.15.3 XZ LAB Patient In-vivo Dosimetry (IVD) System Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 XZ LAB Patient In-vivo Dosimetry (IVD) System Product Portfolio
  • 6.15.5 XZ LAB Recent Developments/Updates

7 Patient In-vivo Dosimetry (IVD) System Manufacturing Cost Analysis

• 7.1 Patient In-vivo Dosimetry (IVD) System Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Patient In-vivo Dosimetry (IVD) System
• 7.4 Patient In-vivo Dosimetry (IVD) System Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Patient In-vivo Dosimetry (IVD) System Distributors List
• 8.3 Patient In-vivo Dosimetry (IVD) System Customers

9 Patient In-vivo Dosimetry (IVD) System Market Dynamics

• 9.1 Patient In-vivo Dosimetry (IVD) System Industry Trends
• 9.2 Patient In-vivo Dosimetry (IVD) System Growth Drivers
• 9.3 Patient In-vivo Dosimetry (IVD) System Market Challenges
• 9.4 Patient In-vivo Dosimetry (IVD) System Market Restraints

10 Global Market Forecast

• 10.1 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Type (2022-2027)
• 10.2 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Application (2022-2027)
• 10.3 Patient In-vivo Dosimetry (IVD) System Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Patient In-vivo Dosimetry (IVD) System by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Patient In-vivo Dosimetry (IVD) System by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List